BOSTON, June 23, 2025 (GLOBE NEWSWIRE) -- Block & Leviton is investigating Hims & Hers Health, Inc. (NYSE: HIMS) for potential securities law violations. Investors who have lost money in their Hims & Hers Health, Inc. investment should contact the firm to learn more about how they might recover those losses. For more details, visit https://blockleviton.com/cases/hims. What is this all about? Shares of Hims & Hers Health fell over 25% on June 23 after Novo Nordisk announced it was terminating its partnership ...

Core Viewpoint - Mobile-health Network Solutions (MNDR) is transitioning to a leaner, asset-light model focused on AI-driven virtual care, aiming for scalability and profitability despite short-term revenue declines due to the closure of its CityGate clinic in Singapore [2][3]. Financial Performance - For H1 FY2025, MNDR reported revenue of US$4.3 million, down from US$6.6 million in H1 FY2024, and a net loss of US$(1.7 million) compared to US$(1.5 million) in the same period last year [7]. - Cash and cash equivalents decreased to US$2.6 million from US$6.7 million in H1 FY2024 [7]. Strategic Initiatives - The closure of the CityGate clinic is seen as a pivotal moment in the company's transformation towards a globally scalable, AI-focused platform [3]. - In April 2025, MNDR acquired Lifepack, enhancing its telehealth and pharmacy services for Indonesia's 280 million people, many of whom are underserved [4]. - The company secured US$10 million in funding in January 2025 to advance its AI-driven healthcare solutions, including the AI Agent platform [5]. Operational Developments - MNDR has integrated AI agents into its MaNaDr app to reduce operational costs while improving care and service delivery [8]. - The launch of AI Notes in March 2025 automates clinical note-taking for doctors, enhancing efficiency [11]. - A tele-dentistry service was announced in May 2025, allowing patients to perform AI-enhanced dental scans at home [11]. Future Outlook - The company anticipates that recent initiatives will lead to higher revenue and aims to achieve breakeven by H2 FY2025 and profitability before H1 FY2027 [9].

Core Insights - Amazon is reorganizing its healthcare business, Amazon Health Services, into six distinct units to enhance efficiency and innovation in addressing the fragmented healthcare experience for patients and customers [2][3]. Group 1: Organizational Changes - The restructuring involves creating six new divisions: One Medical Clinical Care Delivery, One Medical Clinical Operations and Performance, AHS Strategic Growth and Network Development, AHS Store, Tech and Marketing, AHS Compliance, and AHS Pharmacy Services [4]. - The leadership of the new units will include both long-time Amazon leaders and executives from One Medical, indicating a blend of internal and external expertise [2][4]. Group 2: Strategic Direction - The company aims to simplify its structure to move faster and innovate effectively in the healthcare sector [2]. - Amazon is expanding its healthcare offerings, including virtual care and chronic condition management, through strategic partnerships with companies like Teladoc and mental health providers [5]. Group 3: Competitive Landscape - Amazon is competing with Walmart not only for retail dollars but also for healthcare infrastructure, media, and cloud services [4]. - The company is actively working to redefine healthcare access and challenge established players in the industry [5]. Group 4: Recent Developments - In November, Amazon expanded its healthcare services by introducing the Amazon One Medical Pay-per-visit telehealth service, which provides care for various conditions and on-demand messaging visits with clinicians [6].

Core Insights - Recent negative stock market sentiment has led to significant short squeezes, generating substantial returns for certain stocks [1] - A bi-weekly list of stocks that are likely to experience short squeezes has been compiled, focusing on those with high short interest and potential losses for short sellers [2] Group 1: Stocks with Significant Short Interest - Stocks identified for potential short squeezes include Hims & Hers Health Inc (NYSE:HIMS), AST SpaceMobile Inc (NASDAQ:ASTS), and NuScale Power Corp (NYSE:SMR) [3] - The table lists various stocks with their short interest percentage changes, new short interest, and estimated returns for shorts, indicating potential opportunities for investors [4] Group 2: Sector Analysis - The technology and nuclear energy sectors are highlighted as areas where short sellers are facing significant losses, suggesting potential for recovery and investment opportunities [4] - Fast-casual restaurant stocks such as Shake Shack Inc (NYSE:SHAK) and CAVA Group Inc (NYSE:CAVA) are also noted as names to watch due to their performance amidst the current market conditions [4]

Financial Data and Key Metrics Changes - The company has seen a significant increase in membership, with over 100 million members now having access to its services, reflecting a 12% year-over-year growth in members in Q1 [20][23] - The transition from subscription-based models to utilization-based models has created a headwind for top-line growth, although underlying utilization and visits are growing [48][50] Business Line Data and Key Metrics Changes - The integrated care business has over 1 million people enrolled in chronic condition management programs, with a focus on enhancing offerings to drive more value for clients [10][14] - BetterHelp, the direct-to-consumer virtual therapy business, has a significant drop-off rate, with over 80% of users not converting to active users due to high out-of-pocket costs [35][37] Market Data and Key Metrics Changes - The international market represents about 15% of the revenues of integrated care, with expectations to grow upwards of 50% over the next few years [16] - Utilization levels in the U.S. are still in the mid to high single digits, indicating substantial room for growth in engagement and usage [29] Company Strategy and Development Direction - The company is focused on four strategic areas: integrated care, international expansion, operational excellence, and enhancing mental health services [9][19] - There is a strong emphasis on leveraging technology and data to improve engagement and drive better health outcomes, particularly in chronic care and mental health [12][60] Management's Comments on Operating Environment and Future Outlook - Management acknowledges the challenges posed by the shift from subscription to utilization models but remains optimistic about the growth potential in both domestic and international markets [48][50] - The company is committed to creating efficiencies while also investing in technology and capabilities to enhance service delivery [74][75] Other Important Information - The company has made strategic acquisitions, such as Catapult and Uplift, to enhance its capabilities in insurance coverage and chronic care management [61][62] - Adjusted EBITDA margins have remained flat year-over-year, with ongoing efforts to streamline costs and improve productivity [70][71] Q&A Session Summary Question: How does the company plan to grow revenue per integrated care member? - Management indicated that they are focused on a "land and expand" strategy, starting with core telehealth services and expanding into additional products and services [23][24] Question: What is the current mix between subscription and visit-based models? - The majority of the business has shifted to visit-based models post-pandemic, although the exact mix has not been publicly shared [50][51] Question: How does the company plan to maintain its leadership position in chronic disease management? - Management emphasized the importance of innovation and leveraging their extensive data and clinical capabilities to provide greater value than competitors [58][59]

Core Insights - Dogecoin Cash Inc. has received approval to change its stock ticker symbol to DOGP, effective June 10, 2025, aligning with its identity and mission in the decentralized meme economy [1][3] - The company operates a telehealth platform, PrestoDoctor, providing HIPAA-compliant cannabis consultations and holds patents for a cannabis strain and lozenge [2][5] - The new ticker reflects a focus on a meme-forward digital ecosystem and follows significant milestones, including the issuance of a preferred stock dividend [3][7] Company Developments - The common shares will begin trading under the new ticker DOGP on the OTCQB Market starting July 10, 2025, with no action required from shareholders [3] - The company remains compliant with SEC reporting requirements and continues to file under the Securities Exchange Act of 1934 [4] - Recent milestones include the acquisition of 1 billion DOG tokens from Tipestry Inc., the launch of Meme Coins Inc., and the issuance of preferred stock as a dividend [7] Industry Positioning - The ticker change signifies a broader trend of publicly traded companies embracing internet-native culture while adhering to financial regulations [4] - Dogecoin Cash Inc. is positioning itself as a bridge between traditional capital markets and the decentralized, meme-driven future of finance [4]

Market Performance - The small-cap Russell 2000 index increased by +10% over the past month, although it remains down -4% year to date [1] - The S&P 500 index stayed above the 6000 mark, gaining +0.09% on the day, while the Nasdaq rose by +0.31% [3] - The Dow index remained unchanged at 0.00%, influenced by a -1.2% drop in Apple shares [2][5] Company News: Apple - Apple shares fell -1.2% following a lackluster performance at the Worldwide Developers Conference, where details on AI competition were sparse [2] - Apple shares are down -29.5% from their 52-week highs reached after Christmas last year [2] Company News: Casey's General Stores - Casey's General Stores reported fiscal Q4 earnings of $2.63 per share, exceeding the Zacks consensus by 70 cents, with a year-over-year growth of +12.4% [6] - Revenues reached $3.99 billion, surpassing analyst expectations of $3.97 billion [6] - Same-store sales increased by +1.7%, and the company raised its dividend by +14% to 57 cents per share, marking its 26th consecutive increase [7] - Casey's shares are now trading at new all-time highs, reflecting strong performance [7]

Core Insights - Hims & Hers has experienced significant growth in the telehealth market, with a stock increase of 449% since going public and 158% in the past year [1][2] - The company utilizes a subscription model that bypasses traditional insurance, allowing for direct delivery of medications to customers' homes [2][4] - Hims & Hers reported trailing-12-month revenue of $1.78 billion and aims to reach $2.3 billion by 2025 and $6.5 billion by 2030 [4][11][13] Business Model and Market Position - The subscription model has enabled Hims & Hers to dominate the telehealth prescription market, focusing on areas such as sexual health, hair loss, and mental health [2][4] - The company is expanding its offerings by partnering with Novo Nordisk to include the weight loss drug Wegovy in its marketplace [4][5] - Hims & Hers currently has 2.4 million active customers, with management identifying a potential market of over 100 million people [5] International Expansion - Hims & Hers is pursuing international growth through the proposed acquisition of competitor Zava, which serves 1.3 million active customers in Western Europe [7][8] - The acquisition is expected to enhance Hims & Hers' marketing capabilities and scale, facilitating entry into new markets [8][9] Financial Performance and Projections - The company reported a year-over-year sales growth of 111% last quarter, with projections to reach $2.3 billion in revenue by 2025 [11] - Hims & Hers aims for a profit margin of 20% by 2030, which could result in approximately $1.3 billion in annual earnings [13] - The current market capitalization is $12.3 billion, leading to a high price-to-earnings (P/E) ratio of 79, but potential for valuation adjustment as growth continues [12][13]

Company Overview - Mobile-health Network Solutions is a leading MedTech innovator ranked 41 in the Financial Times 2024 listing of 500 High-growth Asia-Pacific Companies [4] - The company is the first telehealth provider from the Asia-Pacific region to be listed in the US, offering personalized and reliable medical attention globally [4] - Its platform enables healthcare providers to reach users through virtual clinics without start-up costs, connecting them to a global network of peer-to-peer support groups and partners [4] Share Repurchase Program - The Board of Directors has approved a share repurchase program to buy back up to 214,000 Class A Ordinary Shares, effective immediately for one year [1] - The program reflects the Board's confidence in the company's long-term growth prospects and is seen as a compelling use of capital at current share prices [2] - Repurchases may occur through various means, including open market transactions and privately negotiated transactions, depending on market conditions and regulatory requirements [2][3] Market Position and Strategy - The company believes its current share price does not reflect its intrinsic value or the strength of its fundamentals [2] - The share repurchase program does not obligate the company to repurchase a specific number of shares and can be modified or terminated at the company's discretion [3]

Core Insights - Doximity (DOCS) experienced strong revenue growth in fiscal 2025, with total revenues for Q4 reaching $138.3 million, a 17% year-over-year increase driven by subscription revenues [1][6] - The demand for telehealth services is expected to continue rising into fiscal 2026, supported by a record number of unique active users and a significant increase in sales to top clients [1][6] - The company's strategic focus is shifting towards clinical AI products, which aligns with the growing demand for productivity-enhancing tools among physicians [2] Company Performance - Doximity's subscription revenue for Q4 was $131.9 million, also reflecting a 17% year-over-year growth [1][6] - Unique active prescribers exceeded 620,000 in Q4, indicating robust engagement with the platform [1] - Sales to the top 20 clients surged by 23% during fiscal 2025, suggesting strong future growth potential [1][6] Product and Service Demand - The newsfeed product saw a 30% year-over-year increase in articles accessed, contributing to record engagement levels [2] - AI tools, including Doximity GPT, were the fastest-growing segment, increasing over 5 times year-over-year [2] - The company is transitioning its focus from client portals to clinical AI products to address physician burnout and enhance monetization opportunities [2] Industry Context - Competitors like HealthEquity (HQY) and Teladoc Health (TDOC) are also experiencing growth, with HQY reporting a 15% increase in sales to $330.8 million in Q1 of fiscal 2026 [3] - Teladoc Health, despite a decline in operational revenues, reported better-than-expected results due to growth in international revenues and an expanding membership base [4] Valuation and Earnings Estimates - Doximity's shares have gained 0.2% year-to-date, contrasting with a 4.3% decline in the industry [5] - The company trades at a forward price-to-earnings ratio of 36.05, above the industry average but lower than its five-year median of 52.54 [8] - The Zacks Consensus Estimate for Doximity's 2025 earnings suggests a 2.8% increase from the previous year [9]